Back to results
US 12,577,229 B2Granted
Substituted {5-methoxy-6-[(5-methoxypyridin-2-yl)methoxy]pyridin-3-yl} methyl compounds as CSF-1R inhibitors
AssigneeEli Lilly and Company
InventorSimon James Richards
Life of this patent
Estimating the term…
Abstract
The present invention provides a compound of Formula I: Formula I or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the compound and to methods of using the compound to treat physiological disorders.
Claims8
A compound of the formula:
- or a pharmaceutically acceptable salt thereof.
A compound of the formula:
Dependencies are inferred from the claim text.